Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development CTO Q1 2026 Earnings Massive EPS Surprise of 374 as FFO Exceeds Expectations AIFU Q3 2023 Earnings Strong EPS Amid Market Volatility LRMR Q1 2026 Earnings StrongerThanExpected Results as Biotech Advances Pipeline EOSE Q1 2026 Earnings EPS Beats Estimates as Eos Energy Advances Commercialization Stock Slips Mexco Energy MXC Q3 2025 Earnings Profitability Maintained Amid Industry Headwinds